D
AVITA Medical, Inc. RCEL
$4.62 -$0.265-5.43% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 35.56% 25.72% -64.03% -86.01% -48.24%
Total Depreciation and Amortization 170.59% 156.65% 118.72% 89.02% 39.73%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -62.28% -27.32% 194.38% 163.43% 77.62%
Change in Net Operating Assets -3,407.84% 103.86% -24,966.67% 181.27% 84.68%
Cash from Operations 19.96% 50.59% 25.61% 19.61% -40.42%
Capital Expenditure 80.24% 80.73% -444.59% -649.00% -786.96%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -50.01% -32.23% 107.16% -49.90% -19.17%
Cash from Investing -43.56% -28.54% 104.31% -66.02% -32.30%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -34.16% -42.47% 52.39% 67.83% 396.49%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -34.16% -42.47% -97.41% 67.83% 396.49%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -629.74% 115.87% 84.03% -91.12% -94.69%